A TGFβ-ECM-integrin signaling axis drives structural reconfiguration of the bile duct to promote polycystic liver disease
Scott H. Waddell(Edinburgh Cancer Research), Luke Boulter(MRC Institute of Genetics and Molecular Medicine), Luca Fabris(University of Bergamo), Melissa M. Boerrigter(Radboud University Nijmegen), Konstantinos Gournopanos(Institute of Genetics and Cancer), Edward J. Jarman(Western General Hospital), Ava Khamseh(Institute of Genetics and Cancer), Pleasantine Mill(University of Edinburgh), Alexander Walker(Institute of Genetics and Cancer), Paula Olaizola(University of the Basque Country), Joost P.H. Drenth(Radboud University Nijmegen), Philippe Gautier(Institute of Genetics and Cancer), Massimiliano Cadamuro(University of Padua), Timothy J. Kendall(MRC Centre for Regenerative Medicine), Jesús M. Bañales(Biogipuzkoa Health Research Institute), Ersi Christodoulou(Institute of Genetics and Cancer), Yuelin Yao(Institute of Genetics and Cancer), Andreea Grãdinaru(Institute of Genetics and Cancer)
Cited by 20
Related Papers
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
|Nature Reviews Gastroenterology & Hepatology|2020|2.4k
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
|Nature Reviews Gastroenterology & Hepatology|2016|1.4k
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
|New England Journal of Medicine|2016|1.1k
Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
|Gastroenterology|2016|1k
United European Gastroenterology evidence‐based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU)
|United European Gastroenterology Journal|2017|698